Mariah S. Stewart

This study examines how phosphorylation at HSP70 T636 affects its binding to CHIP, showing reduced affinity and altered interactions with other co-chaperones, with implications for disease.

The paper identifies antagonistic drug interactions in cancer therapy by analyzing death activation kinetics, finding that single agent dominance occurs due to differences in cell death onset time.